Siegfried Investor Relations Material
Siegfried Holding AG engages in the life sciences business worldwide. The company offers medical devices, instruments, and tools. It also explores and produces magnetic resonance image (MRI) contrast media, as well as medical diagnostic contrast agents in different strengths for use in X-ray imaging; radiolabeled antibodies for radioimmunodetection of malignant tumors; and radioiodinated contrast agents with potential for future use as radiotracers for PET imaging. In addition, it manufactures drug delivery systems such as transdermal systems and transmucosal patches. Siegfried Holding AG sells its products in Europe under several product brands.
Key slides for Siegfried Holding AG
Marvel-ous Reporting: Marvel’s Comic Inspired Reports
Shareholder reports are often considered tedious and dry. However, in the late 1980s and early 1990s, Marvel Comics revolutionized this perception by transforming its financial reports into captivating comic books.
8 Dec 2023
The Payments Value Chain: A Complex Ecosystem
The payments industry is a complex and dynamic field involving multiple key players. These include customers, merchants, issuers, acquirers, card networks, and various other entities together forming the payments value chain.
8 Dec 2023
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023